title: Pegylated liposomal doxorubicin: an efficient treatment in patients with Hodgkin lymphoma relapsing after high dose therapy and stem cell transplation.
authors.forename: Thomas
authors.initials: T
authors.lastname: Clozel
authors.forename: Benedicte
authors.initials: B
authors.lastname: Deau
authors.forename: Claire
authors.initials: C
authors.lastname: Benet
authors.forename: Patricia
authors.initials: P
authors.lastname: Franchi
authors.forename: Marie
authors.initials: M
authors.lastname: Robin
authors.forename: Isabelle
authors.initials: I
authors.lastname: Madelaine
authors.forename: Catherine
authors.initials: C
authors.lastname: Thieblemont
authors.forename: Eric
authors.initials: E
authors.lastname: de Kerviler
authors.forename: Josette
authors.initials: J
authors.lastname: Brière
authors.forename: Pauline
authors.initials: P
authors.lastname: Brice
mesh_terms: D000293:Adolescent; D000328:Adult; D004317:Doxorubicin / Q000031:analogs & derivatives* / Q000627:therapeutic use; D005260:Female; D006689:Hodgkin Disease / Q000188:drug therapy* / Q000473:pathology / Q000601:surgery; D006801:Humans; D008297:Male; D008875:Middle Aged; D009367:Neoplasm Staging; D011092:Polyethylene Glycols / Q000627:therapeutic use; D012008:Recurrence; D012189:Retrospective Studies; D033581:Stem Cell Transplantation; D055815:Young Adult
chemical_list: C506643:liposomal doxorubicin; D011092:Polyethylene Glycols; D004317:Doxorubicin
keywords: Hodgkin lymphoma; drugs; high dose therapy